Brief: Immunogen Announces Departure Of Anna Berkenblit, Chief Medical Officer
31/07/2023 12:20
July 31 (Reuters) - ImmunoGen Inc IMGN.O :
* IMMUNOGEN ANNOUNCES DEPARTURE OF ANNA BERKENBLIT, CHIEF
MEDICAL
OFFICER
Source text for Eikon: ID:nBw9FdjM7a
Further company coverage: IMGN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on ImmunoGen
See all newsBrief: Abbvie Completes Acquisition Of Immunogen
Brief: Abbvie Qtrly Adj EPS $2.79 Vs LSEG IBES Estimate $2.77
Brief: Immunogen Says German Federal Cartel Office Approved Merger With Abbvie Unconditionally
Ambrx Biopharma surges on J&J's buyout announcement
Street View: BioMarin-Elliott settlement likely eases investor frustration